Evidence map›Paper›PMID 33635384›Full record

ArticlePsychopharmacology2021

Sleep-wake cycle disturbances and NeuN-altered expression in adult rats after cannabidiol treatments during adolescence.

Eric Murillo-Rodríguez, Diana Millán-Aldaco, Dorotea Cicconcelli, Valentina Giorgetti, Gloria Arankowsky-Sandoval, Jocelyne Alcaraz-Silva, Claudio Imperatori, Sérgio Machado, Henning Budde, Pablo Torterolo

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 6 countries.

Eric Murillo-RodríguezLaboratorio de Neurociencias Moleculares e Integrativas Escuela de Medicina, División Ciencias de la Salud, Universidad Anáhuac Mayab Mérida, Km. 15.5 Carretera Mérida-Progreso, Int. Km. 2 Carretera a Chablekal, C.P. 97308, Mérida, Yucatán, Mexico. eric.murillo@anahuac.mx.ORCID http://orcid.org/0000-0001-9307-3783
Diana Millán-AldacoDepto. de Neurociencia Cognitiva, División de Neurociencias Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, Mexico.
Dorotea CicconcelliCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Rome, Italy.
Valentina GiorgettiCognitive and Clinical Psychology Laboratory, Department of Human Sciences, European University of Rome, Rome, Italy.
Gloria Arankowsky-SandovalCentro de Investigaciones Regionales "Dr. Hideyo Noguchi", Universidad Autónoma de Yucatán, Mérida, Yucatán, Mexico.
Jocelyne Alcaraz-SilvaLaboratorio de Neurociencias Moleculares e Integrativas Escuela de Medicina, División Ciencias de la Salud, Universidad Anáhuac Mayab Mérida, Km. 15.5 Carretera Mérida-Progreso, Int. Km. 2 Carretera a Chablekal, C.P. 97308, Mérida, Yucatán, Mexico.
Claudio ImperatoriIntercontinental Neuroscience Research Group, Mérida, Yucatán, Mexico.
Sérgio MachadoIntercontinental Neuroscience Research Group, Mérida, Yucatán, Mexico.
Henning BuddeIntercontinental Neuroscience Research Group, Mérida, Yucatán, Mexico.
Pablo TorteroloIntercontinental Neuroscience Research Group, Mérida, Yucatán, Mexico.
European University of Rome · ITAnahuac Mayab University · MXAutonomous University of Yucatán · MXMSH Medical School Hamburg – University of Applied Sciences and Medical University · DENeurosciences Institute · USUniversidad de la República de Uruguay · UYUniversidad Nacional Autónoma de México · MX

Funding

University of California Institute for Mexico and the United States CN-17-19
6 · The paper itself

Abstract

rationaleThe medical uses of cannabidiol (CBD), a constituent of the Cannabis sativa, have accelerated the legal and social acceptance for CBD-based medications but has also given the momentum for questioning whether the long-term use of CBD during the early years of life may induce adverse neurobiological effects in adulthood, including sleep disturbances. Given the critical window for neuroplasticity and neuro-functional changes that occur during stages of adolescence, we hypothesized that CBD might influence the sleep-wake cycle in adult rats after their exposure to CBD during the adolescence.

objectivesHere, we investigated the effects upon behavior and neural activity in adulthood after long-term administrations of CBD in juvenile rats.

methodsWe pre-treated juvenile rats with CBD (5 or 30 mg/Kg, daily) from post-natal day (PND) 30 and during 2 weeks. Following the treatments, the sleep-wake cycle and NeuN expression was analyzed at PND 80.

resultsWe found that systemic injections of CBD (5 or 30 mg/Kg, i.p.) given to adolescent rats (post-natal day 30) for 14 days increased in adulthood the wakefulness and decreased rapid eye movement sleep during the lights-on period whereas across the lights-off period, wakefulness was diminished and slow wave sleep was enhanced. In addition, we found that adult animals that received CBD during the adolescence displayed disruptions in sleep rebound period after total sleep deprivation. Finally, we determined how the chronic administrations of CBD during the adolescence affected in the adulthood the NeuN expression in the suprachiasmatic nucleus, a sleep-related brain region.

conclusionsOur findings are relevant for interpreting results of adult rats that were chronically exposed to CBD during the adolescence and provide new insights into how CBD may impact the sleep-wake cycle and neuronal activity during developmental stages.

Indexed as

AnimalsBrainCannabidiolCannabisMaleNeuronsRatsRats, WistarSleepSleep DeprivationSleep, REMSleep Wake DisordersWakefulnessCannabidiolCannabinoidsSleepSuprachiasmatic nucleusΔ9-Tetrahydrocannabinol

Identifiers

PMID33635384
OpenAlexW3132355323

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.